Finally, pharmaceuticals are moving toward continuous rather than batch processes. This is a huge leap, because it will impact not only the quality and purity of drugs produced, but also many other factors to the producers and consumers.
Siemens is working on it from the manufacturing side. See this article.
The FDA also has issued formal opinion and guidance.